| Age |
1.0120 |
0.000 |
1.0106 |
1.0134 |
| Sex |
| Male |
Reference |
| Female |
0.9321 |
0.000 |
0.9036 |
0.9614 |
| Race |
| White |
Reference |
| Black |
1.0960 |
0.001 |
1.0391 |
1.1559 |
| American Indian, Aleutian or Eskimo |
1.1396 |
0.298 |
0.8910 |
1.4576 |
| Asian |
1.1148 |
0.057 |
0.9968 |
1.2467 |
| Pacific Islander |
1.1473 |
0.181 |
0.9382 |
1.4031 |
| Other |
1.1983 |
0.072 |
0.9836 |
1.4598 |
| Unknown |
0.9130 |
0.188 |
0.7973 |
1.0455 |
| Facility Type |
| Community Cancer Program |
Reference |
| Comprehensive Community Cancer Program |
0.9748 |
0.483 |
0.9079 |
1.0467 |
| Academic/Research Program |
1.0254 |
0.477 |
0.9569 |
1.0989 |
| Integrated Network Cancer Program |
0.9861 |
0.763 |
0.9005 |
1.0799 |
| Unknown |
1.2577 |
0.000 |
1.1475 |
1.3785 |
| Histology |
| Sarcoma, NOS |
Reference |
| Ewing's sarcoma |
1.0035 |
0.961 |
0.8738 |
1.1524 |
| Epithelioid sarcoma |
1.0887 |
0.241 |
0.9446 |
1.2547 |
| High grade undifferentiated pleomorphic sarcoma |
0.7654 |
0.000 |
0.7310 |
0.8014 |
| Fibrosarcoma |
0.9112 |
0.003 |
0.8561 |
0.9698 |
| Solitary fibrous tumor |
0.9660 |
0.765 |
0.7696 |
1.2124 |
| Dermatofibrosarcoma protuberans |
0.7368 |
0.014 |
0.5783 |
0.9389 |
| Liposarcoma, NOS |
0.7990 |
0.000 |
0.7158 |
0.8918 |
| Liposarcoma, well differentiated |
0.8663 |
0.427 |
0.6080 |
1.2344 |
| Myxoid liposarcoma |
0.7606 |
0.000 |
0.6817 |
0.8486 |
| Round cell liposarcoma |
0.7114 |
0.000 |
0.5917 |
0.8554 |
| Pleomorphic liposarcoma |
0.8079 |
0.000 |
0.7405 |
0.8815 |
| Dedifferentiated liposarcoma |
0.8865 |
0.004 |
0.8164 |
0.9626 |
| Leiomyosarcoma |
0.8588 |
0.000 |
0.8162 |
0.9036 |
| Vascular sarcoma |
1.1261 |
0.007 |
1.0324 |
1.2282 |
| Rhabdomyosarcoma |
0.9454 |
0.351 |
0.8403 |
1.0637 |
| Synovial sarcoma |
0.9688 |
0.443 |
0.8933 |
1.0506 |
| Clear cell sarcoma |
1.0210 |
0.880 |
0.7797 |
1.3371 |
| Chondrosarcoma |
0.9042 |
0.234 |
0.7658 |
1.0675 |
| Malignant giant cell tumor |
0.5523 |
0.006 |
0.3630 |
0.8402 |
| Malignant peripheral nerve sheath tumor |
1.0622 |
0.147 |
0.9789 |
1.1525 |
| Alveolar soft part sarcoma |
0.6916 |
0.110 |
0.4397 |
1.0877 |
| Grade |
| Grade 3 |
Reference |
| Grade 4 |
1.0136 |
0.402 |
0.9821 |
1.0460 |
| Tumor Size |
1.0004 |
0.000 |
1.0003 |
1.0005 |
| Charlson-Deyo Score |
| no comorbid conditions |
Reference |
| 1 comorbid condition |
1.1577 |
0.000 |
1.1190 |
1.1979 |
| >1 comorbid condition |
1.4249 |
0.000 |
1.3335 |
1.5226 |
| Radiation-Surgery Sequence |
| No radiation therapy |
Reference |
| Radiation therapy before surgery |
0.8936 |
0.000 |
0.8519 |
0.9373 |
| Radiation therapy after surgery |
0.7649 |
0.000 |
0.7395 |
0.7911 |
| Chemotherapy |
| No chemotherapy |
Reference |
| Received chemotherapy |
0.9868 |
0.518 |
0.9479 |
1.0273 |
| Unknown |
0.8417 |
0.000 |
0.7654 |
0.9255 |
| Margin Status |
| R0 |
Reference |
| R1 |
1.2057 |
0.000 |
1.1472 |
1.2671 |
| R2 |
1.3518 |
0.000 |
1.2776 |
1.4303 |
